Efficacy Vs Tolerability in Bipolar Depression

Slideshow

Which is more important, for whom?

Recent Videos
journey
Related Content
A poster presented at the 2024 ASCP Annual Meeting discussed the results of a study analyzing the treatment’s safety and efficacy in this patient population.

Evaluating the Efficacy of Lumateperone for MDD and Bipolar Depression With Mixed Features

Erin O'Brien
May 30th 2024
Article
Blue Light, Depression, and Bipolar Disorder

Blue Light, Depression, and Bipolar Disorder

Chris Aiken, MD;Kellie Newsome, PMH-NP
August 4th 2021
Podcast
An expert discusses the role of cognition in bipolar disorder and the potential of modafinil as a treatment for it at the 2024 ASCP Annual Meeting.

Efficacy of Modafinil for Treatment of Neurocognitive Impairment in Bipolar Disorder

Erin O'Brien
May 29th 2024
Article
Four Myths About Lamotrigine

Four Myths About Lamotrigine

Chris Aiken, MD;Kellie Newsome, PMH-NP
August 3rd 2021
Podcast
How can we enhance our lithium research?

Securing the Future of Lithium Research

Alex Mendelsohn, PhD;Awais Aftab, MD
May 27th 2024
Article
An expert shares some clinical pearls from his lecture at the recent American Psychiatric Association Annual Meeting.

An Update on Early Intervention in Psychotic Disorders

Dost Ongur, MD, PhD
May 21st 2024
Article
© 2024 MJH Life Sciences

All rights reserved.